This article originally appeared on Cure.

According to a recent study presented at the 2017 annual meeting of the American Association for Cancer Research, the number of cancer cases diagnosed among people with HIV is projected to decline in the coming years, mostly due to declines in the rates of non-Hodgkin lymphoma and Kaposi sarcoma.

Researchers determined that the 7,909 cases of cancer diagnosed among people living with HIV in 2010 will drop to 6,495 cases in 2030. Of those, the rate of AIDS-defining cancers —cancers which mark the progression from HIV to AIDS, which are Kaposi sarcoma, non-Hodgkin lymphoma and cervical cancer — is expected to drop from 2,719 cases in 2010 to 710 cases in 2030. The most common cancers in this population is expected to shift from Kaposi sarcoma and non-Hodgkin lymphoma in 2010, to prostate, lung, liver and anal cancer in 2030.

In an interview with CURE, Jessica Yasmine Islam, M.P.H., a doctoral student at Gillings School of Global Public Health at the University of North Carolina, Chapel Hill, and the study’s lead author, discussed the results that were presented at the meeting, as well as the implications this study has for the future.

Read the full post >>